More about Archean Chemical Industries Limited
Fundamentals for Archean Chemical Industries Limited
Regulatory Filings for Archean Chemical Industries Limited
The Renewable Success Story Beyond Solar
Startups Mint India’s New Billionaires
India's Biggest IPO Has a Bigger Meaning
From Watches to Wealth: Titan's New Empire
Fundamentals for Archean Chemical Industries Limited
Business Operations:
Sector: Basic MaterialsIndustry: Chemicals
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.
Revenue projections:
Investors may be wary of Archean Chemical Industries Limited as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.
Financial Ratios:
| currentRatio | 1.212000 |
|---|---|
| forwardPE | 15.495911 |
| debtToEquity | 24.128000 |
| earningsGrowth | -0.731000 |
| revenueGrowth | -0.129000 |
| grossMargins | 0.925460 |
| operatingMargins | 0.070580 |
| trailingEps | 8.670000 |
| forwardEps | 33.625000 |
Archean Chemical Industries Limited's current ratio 1.212, suggesting the company has sufficient liquidity to service its short-term debt. With its cash reserves and current assets in good shape, Archean Chemical Industries Limited can comfortably meet its immediate liabilities, reflecting a healthy financial standing.
ACI's Forward PE ratio suggests the stock price is reasonable in relation to earnings. It's not overpriced, providing room for future growth, making the stock a potentially valuable investment for those seeking long-term gains.
Archean Chemical Industries Limited's low Debt-to-Equity ratio shows that the company avoids excessive reliance on debt, reducing financial risk. This suggests a more secure financial position with less vulnerability to debt-related risks, making Archean Chemical Industries Limited a stable and conservative investment.
ACI's low earnings and revenue growth suggest that the company may face shrinking profits. This could indicate underlying financial challenges, making it difficult for ACI to sustain its current profitability.
ACI's negative gross and operating margins suggest that the company is currently facing financial difficulties, as it is unable to cover production and operational costs. This could result in significant losses if not addressed.
Archean Chemical Industries Limited's forward EPS exceeds its trailing EPS, indicating that the company is projected to be more profitable in the current financial year compared to the previous one. This suggests positive growth and improved earnings, signaling an optimistic outlook for Archean Chemical Industries Limited's financial performance.
Price projections:
ACI's price has consistently been situated near the lower end of expected values. This ongoing trend may reflect investor skepticism about the company's growth potential and overall performance.
Insider Transactions:
There were 1 buy transactions of Archean Chemical Industries Limited stock, with market price at 627.5499877929688 per share.No buy transactions were carried out during the period under review.More sells than buys at ACI's current price levels suggest a potential downside. If this selling trend persists, it could trigger further price declines, as increased selling often reflects investor pessimism about the stock's future prospects.
Recommendation changes over time:
Analysts have recently developed a sell bias for Archean Chemical Industries Limited, suggesting caution when making investment decisions. Investors are advised to rely on a broad range of market indicators rather than solely on this bias to ensure a more comprehensive understanding of the stock's potential before taking action.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
SEBI's New Gateway Is Rewiring Foreign Investment in India
Why Japan Backs India’s Truckers
India's $69B Eurasian Trade Power Play